Evidence map›Paper›PMID 35002459›Full record

ArticleSaudi journal of biological sciences2022

Designing an immunoinformatic vaccine for

Pradeep Kumar Yadalam, Santhiya Rengaraj, Maryam H Mugri, Mohammed Sayed, Amit Porwal, Nasser Mesfer Alahmari, Khaled M Alzahrani, Ali Robaian, Hosam Ali Baeshen, Shankargouda Patil

Open access · hybridAbstract read
In one paragraph

Article in Saudi journal of biological sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Vaccine Design againstFrontiers in dentistry · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Molecules (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Pradeep Kumar YadalamDepartment of Periodontics, Adhi Parashakthi Dental College and Hospital, Melvaruvathur, India.
Santhiya RengarajDepartment of Periodontics, Adhi Parashakthi Dental College and Hospital, Melvaruvathur, India.
Maryam H MugriDepartment of Maxillofacial Surgery and Diagnostic Sciences, College of Dentistry, Jazan University, Jazan 45412, Saudi Arabia.
Mohammed SayedDepartment of Prosthetic Dental Sciences, College of Dentistry, Jazan University, Jazan 45412, Saudi Arabia.
Amit PorwalDepartment of Prosthetic Dental Sciences, College of Dentistry, Jazan University, Jazan 45412, Saudi Arabia.
Nasser Mesfer AlahmariDepartment of Prosthodontics, Dental College, King Khalid University, Abha, Saudi Arabia.
Khaled M AlzahraniDepartment of Prosthetic Dental Sciences, College of Dentistry, Prince Sattam Bin AbdulAziz University, Al-Kharj, Saudi Arabia.
Ali RobaianDepartment of Conservative Dental Sciences, College of Dentistry, Prince Sattam bin Abdulaziz University, Al-Kharj, Saudi Arabia.
Hosam Ali BaeshenDepartment of Orthodontics, Faculty of Dentistry, King Abduaziz University, Jeddah 21589, Saudi Arabia.
Shankargouda PatilDepartment of Maxillofacial Surgery and Diagnostic Sciences, Division of Oral Pathology, College of Dentistry, Jazan University, Jazan, Saudi Arabia.
Jazan University · SAMNR Dental College and Hospital · INPrince Sattam Bin Abdulaziz University · SAKing Abdulaziz University · SAKing Khalid University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesPeri-implantitis is a destructive inflammatory process that affects the soft and hard tissues around dental implants. MATERIALS AND

methods

resultsThe designed vaccine was non-allergenic and had a high antigenicity, solubility, and stability. The 3D structure of the vaccine revealed strong interaction with CXCR4(TLR2) using molecular docking. The vaccine-CXCR4 interface was more consistent, possibly because the vaccination has a higher affinity for the CXCR4-TLR2 complex.

conclusionThis study details the vaccine's distinct and sustained interaction with the CXCR4(TLR2) immunological receptor and its consistent and effective utterance in the bacterial system. As a result, our vaccine formulation will evoke a significant memory response and induce an adaptive immune response against

Indexed as

CXCR4Immunoinformatics approachMulti-epitope vaccinePeri-implantitisPorphyromonas gingivalis

Identifiers

PMID35002459
PMCPMC8716954
OpenAlexW3201486584

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.